Clinical Trials Browser

Observational × Neoplasm, Residual × 90 days × Clear all

Biliary Tract Neoplasms, Gallbladder Neoplasms, Neoplasms, Cholangiocarcinoma, Klatskin Tumor, Neoplasm, Residual

NCT07211178 2026-03-04

GEMINI Breast

Recruiting

900 enrolled

Breast

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT07291921 2026-03-03

To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)

Recruiting

100 enrolled

Thoracic

Lung Neoplasms, Neoplasm, Residual

NCT07382505 2026-02-02

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

Not yet recruiting

600 enrolled

Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms, Endometrial Neoplasms, Neoplasm, Residual

NCT01499394 2026-01-21

Caris Biorepository Research Protocol

Recruiting

100,000 enrolled

Tumor-Agnostic

Neoplasms, Neoplasm, Residual

NCT07356882 2026-01-21

EURHOLY

Recruiting

400 enrolled

Tumor-Agnostic

Neoplasm, Residual

NCT07112612 2026-01-12

Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer

Not yet recruiting

50 enrolled

Genitourinary

Prostatic Neoplasms, Neoplasm, Residual

NCT05625971 2026-01-07

NIRVANA

Completed

36 enrolled

Plasma cell

Neoplasm, Residual, Neoplasms, Plasma Cell

NCT04679285 2025-12-23

FERTILAM

Completed

9 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

Clinical Trials

TRACE-BTC

GEMINI Breast

To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigenetics, and Establish Non-invasive Dynamic Follow-up Monitoring Programs During Perioperative and Postoperative Periods (Observational Study)

Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

Caris Biorepository Research Protocol

EURHOLY

Minimal Residual Disease Used in Predicting Therapeutic Efficacy in Metastatic Hormone-sensitive Prostate Cancer

NIRVANA

FERTILAM